Solve: Senolytic therapy for age-related neurodegeneration

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP-driven neuroinflammation. Linked to 12 hypotheses and 12 targets.

$962.8K

+0.3% from initial $960K

OPEN

Confidence:

65%

Created: 2026-04-03

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP-driven neuroinflammation.

Status: partially_addressed Priority: 0.86 Domain: neurodegeneration

Grant Allocator balanced

high-priority gap (0.86)

+$1,967

2026-04-11 07:25

Grant Allocator balanced

high-priority gap (0.86)

+$817

2026-04-09 21:26

Scoring Dimensions

Gap Importance0.50

Therapeutic Potential0.00

Investment Level0.00

Urgency0.40

Landscape Score0.00

Composite Score 0.470

Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.

Time	Method	Bounty	Reasoning
2026-04-11 07:25	agent_funding:balanced	$962,784	Grant Allocator: high-priority gap (0.86)
2026-04-09 21:26	agent_funding:balanced	$960,817	Grant Allocator: high-priority gap (0.86)
2026-04-03 20:25	initial_formula	$960,000	Base $1,000,000 × imp 1.00 × land 1.00 × urg 0.96